Yield10 Bioscience (NASDAQ:YTEN) Receiving Somewhat Favorable News Coverage, Study Shows

News headlines about Yield10 Bioscience (NASDAQ:YTEN) have trended somewhat positive on Friday, Accern reports. Accern scores the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Yield10 Bioscience earned a news sentiment score of 0.11 on Accern’s scale. Accern also assigned news coverage about the specialty chemicals company an impact score of 46.0214284193945 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Shares of Yield10 Bioscience (NASDAQ YTEN) traded down $0.05 on Friday, hitting $1.57. 142,138 shares of the stock were exchanged, compared to its average volume of 567,656. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.41. The stock has a market capitalization of $13.64, a price-to-earnings ratio of -0.55 and a beta of 3.45. Yield10 Bioscience has a twelve month low of $1.54 and a twelve month high of $9.30.

Yield10 Bioscience (NASDAQ:YTEN) last announced its earnings results on Thursday, November 9th. The specialty chemicals company reported ($0.59) earnings per share (EPS) for the quarter. Yield10 Bioscience had a negative return on equity of 214.42% and a negative net margin of 743.10%. The business had revenue of $0.22 million for the quarter.

TRADEMARK VIOLATION NOTICE: “Yield10 Bioscience (NASDAQ:YTEN) Receiving Somewhat Favorable News Coverage, Study Shows” was first posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://ledgergazette.com/2018/01/13/yield10-bioscience-yten-getting-somewhat-positive-press-coverage-study-finds-2.html.

About Yield10 Bioscience

Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.

Insider Buying and Selling by Quarter for Yield10 Bioscience (NASDAQ:YTEN)

Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply